{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T09:13:44Z","timestamp":1768727624303,"version":"3.49.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T00:00:00Z","timestamp":1614124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The epidemic spread of Zika virus (ZIKV), associated with devastating neurologic syndromes, has driven the development of multiple ZIKV vaccines candidates. An effective vaccine should induce ZIKV-specific T cell responses, which are shown to improve the establishment of humoral immunity and contribute to viral clearance. Here we investigated how previous immunization against Japanese encephalitis virus (JEV) and yellow fever virus (YFV) influences T cell responses elicited by a Zika purified-inactivated virus (ZPIV) vaccine. We demonstrate that three doses of ZPIV vaccine elicited robust CD4 T cell responses to ZIKV structural proteins, while ZIKV-specific CD4 T cells in pre-immunized individuals with JEV vaccine, but not YFV vaccine, were more durable and directed predominantly toward conserved epitopes, which elicited Th1 and Th2 cytokine production. In addition, T cell receptor repertoire analysis revealed preferential expansion of cross-reactive clonotypes between JEV and ZIKV, suggesting that pre-existing immunity against JEV may prime the establishment of stronger CD4 T cell responses to ZPIV vaccination. These CD4 T cell responses correlated with titers of ZIKV-neutralizing antibodies in the JEV pre-vaccinated group, but not in flavivirus-na\u00efve or YFV pre-vaccinated individuals, suggesting a stronger contribution of CD4 T cells in the generation of neutralizing antibodies in the context of JEV-ZIKV cross-reactivity.<\/jats:p>","DOI":"10.3389\/fimmu.2021.640190","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T04:32:43Z","timestamp":1614141163000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine"],"prefix":"10.3389","volume":"12","author":[{"given":"Noemia S.","family":"Lima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damee","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Darko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael A.","family":"De La Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leyi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Koren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard G.","family":"Jarman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth H.","family":"Eckels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nelson L.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayvon","family":"Modjarrad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Douek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydie","family":"Trautmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","article-title":"Zika virus: history, emergence, biology, and prospects for control","volume":"130","author":"Weaver","year":"2016","journal-title":"Antiviral Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijid.2016.02.001","article-title":"Rapid spread of zika virus in the Americas\u2013implications for public health preparedness for mass gatherings at the 2016 Brazil olympic games","volume":"44","author":"Petersen","year":"2016","journal-title":"Int. J. Infect. Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/S0140-6736(16)30058-7","article-title":"Guillain-Barre syndrome associated with Zika virus infection","volume":"387","author":"Brasil","year":"2016","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1056\/NEJMoa1602412","article-title":"Zika virus infection in pregnant women in Rio de Janeiro","volume":"375","author":"Brasil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"e48460","DOI":"10.7554\/eLife.48460","article-title":"Zika seroprevalence declines and neutralizing antibodies wane in adults following outbreaks in French Polynesia and Fiji","volume":"9","author":"Henderson","year":"2020","journal-title":"Elife."},{"key":"B6","doi-asserted-by":"publisher","first-page":"aao6975","DOI":"10.1126\/scitranslmed.aao6975","article-title":"Postnatal zika virus infection is associated with persistent abnormalities in brain structure, function, and behavior in infant macaques","volume":"10","author":"Mavigner","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"12802","DOI":"10.1038\/s41598-019-49209-7","article-title":"Postnatal Zika virus infection of nonhuman primate infants born to mothers infected with homologous Brazilian Zika virus","volume":"9","author":"Maness","year":"2019","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"aao4163","DOI":"10.1126\/scitranslmed.aao4163","article-title":"Durability and correlates of vaccine protection against Zika virus in rhesus monkeys","volume":"9","author":"Abbink","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1007474","DOI":"10.1371\/journal.ppat.1007474","article-title":"CD4+ T cells promote humoral immunity and viral control during Zika virus infection","volume":"15","author":"Elong Ngono","year":"2019","journal-title":"PLoS Pathog."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3136","DOI":"10.1038\/s41467-018-05519-4","article-title":"Critical role of CD4(+) T cells and IFNgamma signaling in antibody-mediated resistance to Zika virus infection","volume":"9","author":"Lucas","year":"2018","journal-title":"Nat. Commun."},{"key":"B11","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nmicrobiol.2017.36","article-title":"Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8(+) T cells","volume":"2","author":"Wen","year":"2017","journal-title":"Nat. Microbiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.chom.2016.12.010","article-title":"Mapping and role of the CD8(+) T cell response during primary Zika virus infection in mice","volume":"21","author":"Elong Ngono","year":"2017","journal-title":"Cell Host Microbe."},{"key":"B13","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1590\/0074-02760160332","article-title":"First detection of natural infection of Aedes aegypti with Zika virus in Brazil and throughout South America","volume":"111","author":"Ferreira-de-Brito","year":"2016","journal-title":"Mem. Inst. Oswaldo Cruz."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1056\/NEJMc1604449","article-title":"Evidence of sexual transmission of Zika virus","volume":"374","author":"D'Ortenzio","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S1473-3099(16)00095-5","article-title":"Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study","volume":"16","author":"Calvet","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1016\/S1473-3099(16)30518-7","article-title":"Epidemic arboviral diseases: priorities for research and public health","volume":"17","author":"Wilder-Smith","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e00055","DOI":"10.1128\/MMBR.00055-16","article-title":"The antigenic structure of Zika virus and its relation to other flaviviruses: implications for infection and immunoprophylaxis","volume":"81","author":"Heinz","year":"2017","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science."},{"key":"B19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature18938","article-title":"Structural basis of potent Zika-dengue virus antibody cross-neutralization","volume":"536","author":"Barba-Spaeth","year":"2016","journal-title":"Nature."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e01469","DOI":"10.1128\/JVI.01469-17","article-title":"Prior dengue virus exposure shapes T cell immunity to Zika virus in humans","volume":"91","author":"Grifoni","year":"2017","journal-title":"J. Virol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41598-017-18781-1","article-title":"T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses","volume":"8","author":"Reynolds","year":"2018","journal-title":"Sci. Rep."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0006000","DOI":"10.1371\/journal.pntd.0006000","article-title":"Ontogeny of the B- and T-cell response in a primary Zika virus infection of a dengue-naive individual during the 2016 outbreak in Miami, FL","volume":"11","author":"Ricciardi","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"274","DOI":"10.20411\/10.20411\/pai.v2i2.188","article-title":"T-cell responses in individuals infected with Zika virus and in those vaccinated against dengue virus","volume":"2","author":"Paquin-Proulx","year":"2017","journal-title":"Pathog. Immun."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e00089","DOI":"10.1101\/2020.01.17.911099","article-title":"T cell responses induced by attenuated flavivirus vaccination are specific and show limited cross-reactivity with other flavivirus species","volume":"94","author":"Grifoni","year":"2020","journal-title":"J. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e1006487","DOI":"10.1371\/journal.ppat.1006487","article-title":"Impact of prior flavivirus immunity on Zika virus infection in rhesus macaques","volume":"13","author":"McCracken","year":"2017","journal-title":"PLoS Pathog."},{"key":"B26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"Barrett","year":"2009","journal-title":"Curr. Opin. Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"Guy","year":"2011","journal-title":"Vaccine."},{"key":"B28","doi-asserted-by":"publisher","first-page":"l5710","DOI":"10.1136\/bmj.l5710","article-title":"Is Dengvaxia a useful vaccine for dengue endemic areas?","volume":"367","author":"Gubler","year":"2019","journal-title":"BMJ."},{"key":"B29","doi-asserted-by":"publisher","first-page":"19953","DOI":"10.1038\/srep19953","article-title":"Cross-protection induced by Japanese encephalitis vaccines against different genotypes of Dengue viruses in mice","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"key":"B30","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/S0140-6736(17)33105-7","article-title":"Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials","volume":"391","author":"Gaudinski","year":"2018","journal-title":"Lancet."},{"key":"B31","doi-asserted-by":"publisher","first-page":"13206","DOI":"10.1038\/s41598-018-31375-9","article-title":"Chimeric yellow fever 17D-Zika virus (ChimeriVax-Zika) as a live-attenuated Zika virus vaccine","volume":"8","author":"Giel-Moloney","year":"2018","journal-title":"Sci. Rep."},{"key":"B32","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0140-6736(17)33106-9","article-title":"Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials","volume":"391","author":"Modjarrad","year":"2018","journal-title":"Lancet."},{"key":"B33","doi-asserted-by":"publisher","first-page":"e0202820","DOI":"10.1371\/journal.pone.0202820","article-title":"Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challenge","volume":"13","author":"Cox","year":"2018","journal-title":"PLoS ONE."},{"key":"B34","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.03.016","article-title":"Modified mRNA Vaccines Protect against Zika Virus Infection","volume":"169","author":"Richner","year":"2017","journal-title":"Cell."},{"key":"B35","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41579-018-0039-7","article-title":"Zika virus vaccines","volume":"16","author":"Abbink","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/s41591-019-0746-2","article-title":"Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue-experienced donor","volume":"26","author":"Dussupt","year":"2020","journal-title":"Nat. Med."},{"key":"B37","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.4049\/jimmunol.135.6.4201","article-title":"The association of enhancing antibodies with seroconversion in humans receiving a dengue-2 live-virus vaccine","volume":"135","author":"Eckels","year":"1985","journal-title":"J. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1084\/jem.20151517","article-title":"Human T cell responses to Japanese encephalitis virus in health and disease","volume":"213","author":"Turtle","year":"2016","journal-title":"J. Exp. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e1938","DOI":"10.1371\/journal.pntd.0001938","article-title":"T-cell memory responses elicited by yellow fever vaccine are targeted to overlapping epitopes containing multiple HLA-I and -II binding motifs","volume":"7","author":"de Melo","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/viro.2001.1255","article-title":"Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E","volume":"293","author":"Co","year":"2002","journal-title":"Virology."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.4049\/jimmunol.1202234","article-title":"Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response","volume":"190","author":"Blom","year":"2013","journal-title":"J. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e26494","DOI":"10.1371\/journal.pone.0026494","article-title":"Human leukocyte antigen (HLA) class I restricted epitope discovery in yellow fewer and dengue viruses: importance of HLA binding strength","volume":"6","author":"Lund","year":"2011","journal-title":"PLoS ONE."},{"key":"B43","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1172\/JCI73639","article-title":"PD-1 identifies the patient-specific CD8(+) tumor-reactive repertoire infiltrating human tumors","volume":"124","author":"Gros","year":"2014","journal-title":"J. Clin. Invest."},{"key":"B44","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12","author":"Bolotin","year":"2015","journal-title":"Nat. Methods."},{"key":"B45","unstructured":"OksanenJBF FriendlyM KindtR LegendreP McGlinnD MinchinPR Vegan: Community Ecology Package2020"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1101\/gr.092759.109","article-title":"Circos: an information aesthetic for comparative genomics","volume":"19","author":"Krzywinski","year":"2009","journal-title":"Genome Res."},{"key":"B47","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-3-540-35306-5_10","article-title":"SeqinR 1.0-2: a contributed package to the R project for statistical computing devoted to biological sequences retrieval and analysis","volume-title":"Structural Approaches to Sequence Evolution","author":"Charif","year":"2007"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.1172\/JCI124443","article-title":"Bystander responses impact accurate detection of murine and human antigen-specific CD8 T cells","volume":"129","author":"Martin","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"8032","DOI":"10.1128\/JVI.72.10.8032-8036.1998","article-title":"Establishment and characterization of Japanese encephalitis virus-specific, human CD4(+) T-cell clones: flavivirus cross-reactivity, protein recognition, and cytotoxic activity","volume":"72","author":"Aihara","year":"1998","journal-title":"J. Virol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science."},{"key":"B51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41541-020-0167-8","article-title":"An optimized purified inactivated Zika vaccine provides sustained immunogenicity and protection in cynomolgus macaques","volume":"5","author":"Lecouturier","year":"2020","journal-title":"NPJ Vaccines."},{"key":"B52","doi-asserted-by":"publisher","first-page":"12794","DOI":"10.1128\/JVI.01160-13","article-title":"Yellow fever vaccination elicits broad functional CD4+ T cell responses that recognize structural and nonstructural proteins","volume":"87","author":"James","year":"2013","journal-title":"J. Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/cix732","article-title":"Innate, T-, and B-cell responses in acute human Zika patients","volume":"66","author":"Lai","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e1006184","DOI":"10.1371\/journal.ppat.1006184","article-title":"Analysis of the T cell response to Zika virus and identification of a novel CD8+ T cell epitope in immunocompetent mice","volume":"13","author":"Pardy","year":"2017","journal-title":"PLoS Pathog."},{"key":"B55","doi-asserted-by":"publisher","first-page":"577546","DOI":"10.3389\/fimmu.2020.577546","article-title":"Japanese encephalitis virus vaccination elicits cross-reactive HLA-class I-restricted CD8 T cell response against Zika virus infection","volume":"11","author":"Tarbe","year":"2020","journal-title":"Front. Immunol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"7919","DOI":"10.4049\/jimmunol.0803903","article-title":"The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response","volume":"183","author":"Akondy","year":"2009","journal-title":"J. Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/nri3014","article-title":"Immunity to dengue virus: a tale of original antigenic sin and tropical cytokine storms","volume":"11","author":"Rothman","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"6104054","DOI":"10.1155\/2017\/6104054","article-title":"IL-10: a multifunctional cytokine in viral infections","volume":"2017","author":"Rojas","year":"2017","journal-title":"J. Immunol. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","article-title":"Antibody-dependent enhancement of severe dengue disease in humans","volume":"358","author":"Katzelnick","year":"2017","journal-title":"Science."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.640190\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T21:04:55Z","timestamp":1697922295000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.640190\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2021.640190"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.640190","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]},"article-number":"640190"}}